ITI Life Sciences Signs Commercialisation Licence Agreements with Edinburgh Instruments and Almac Sciences (Scotland)

Published: Feb 28, 2007

Dundee, Scotland, ITI Life Sciences today announced the signing of two Commercialisation Licence agreements based on intellectual assets created during ITI Life Sciences’ Fluorescence Lifetime Assay Programme, using fluorescence lifetime for 3-D cell-based assays and other applications.

Back to news